Schizophrenia Research

Schizophrenia is a chronic, debilitating mental disorder affecting 1-2% of the global population. Symptoms are split into two types; 'positive' symptoms, including delusions and hallucinations, and 'negative' symptoms, including anhedonia and lack of motivation. Studies suggest that genetics, early environment, neurobiology, psychological and social processes are important contributory factors; some recreational and prescription drugs appear to cause or worsen symptoms. Several neurobiological alterations in brain structure, physiology and neurochemistry have been documented, along with an ever-increasing list of susceptibility genes.

Schizophrenia Research Products Targets

Products for Schizophrenia Research - Page 33

  1. Cat.No. Product Name Information/Activity
  2. BCC5971 HU 308 Potent and selective CB<sub>2</sub> agonist HU 308 chemical structure
  3. BCC5744 JWH 015 155471-08-2 JWH 015 chemical structure
  4. BCC1353 AM630 6-Iodopravadoline (AM630) is a selective CB2 antagonist with Ki of 31.2 nM, and displays 165-fold selectivity over CB1 receptors. AM630 chemical structure
  5. BCC6282 COR 170 1048039-15-1 COR 170 chemical structure
  6. BCC7380 JTE 907 282089-49-0 JTE 907 chemical structure
  7. BCC4410 BML-190 Potent, selective CB<sub>2</sub> ligand,BML-190 is a selective cannabinoid CB2 receptor inverse agonist with Ki of 435 nM, with 50-fold selectivity over CB1 receptor. BML-190 chemical structure
  8. BCC7011 Abn-CBD 22972-55-0 Abn-CBD chemical structure
  9. BCC7487 O-1602 317321-41-8 O-1602 chemical structure
  10. BCC7084 Oleylethanolamide Oleoylethanolamide is a high affinity endogenous PPAR-α agonist, which plays an important role in the treatment of obesity and arteriosclerosis. Oleylethanolamide chemical structure
  11. BCC6828 Palmitoylethanolamide Impulsin (AM 3112) is an active endogenous compound which can used for preventing virus infection of the respiratory tract. Palmitoylethanolamide chemical structure

Items 321 to 330 of 709 total